Skip to main
MYO
MYO logo

Myomo (MYO) Stock Forecast & Price Target

Myomo (MYO) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Myomo Inc. has demonstrated notable growth in its reimbursement pipeline, increasing from 1,389 units in Q4 to 1,611 units in Q1, indicating a positive trend in market demand for its myoelectric orthosis products. The company's strategic focus on redirecting growth towards the large Medicare market is expected to bolster revenues, particularly as orthotics and prosthetics providers account for approximately 22% of projected revenue in 2024. Furthermore, a recent favorable ruling from the Centers for Medicare & Medicaid Services (CMS) to include MyoPro in Medicare Part B benefits significantly expands the company's addressable market, enhancing its financial outlook.

Bears say

Myomo Inc. has significantly reduced its revenue guidance for 2025 to $40-42 million, a decrease from the previous forecast of $50-53 million, indicating a declining outlook for the company’s financial performance. Furthermore, the company is experiencing challenges with its marketing efforts and pipeline quality, which have adversely impacted lead quality and conversion rates, suggesting difficulties in future customer acquisition. Additionally, the authorized insurance backlog has decreased to 230, down from 249 in Q1 and 272 in Q4, indicating a downward trend in demand for Myomo's products and potential cash flow concerns.

Myomo (MYO) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Myomo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Myomo (MYO) Forecast

Analysts have given Myomo (MYO) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Myomo (MYO) has a Strong Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Myomo (MYO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.